40 results
8-K
EX-4.6
TEVA
Teva- Pharmaceutical Industries Ltd.
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
.
“Emission Reduction Target” means the Guarantor’s target to reduce the Scope 1 and 2 greenhouse gas (GHG) emissions by no less than 25 … % as of the Testing Date (measured on a calendar year basis and compared to the 2019 baseline); provided, however, that for purposes of determining if the Emission
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
the Emission Reduction Target as of the Testing Date(each as defined in the Euro Notes Supplemental Indenture and the USD Notes Supplemental Indenture … Target as of the Testing Date; and
(c) 0.150% of the principal amount repaid unless Teva has achieved the Emission Reduction Target as of the Testing
8-K
EX-4.2
jskv2imrpbd zg
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-1.1
1eh7nszyems24i6i13id
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
424B5
wx9206y3g gub
4 Nov 21
Prospectus supplement for primary offering
4:41pm
FWP
8c8s6at10wfot
2 Nov 21
Free writing prospectus
5:29pm
424B3
sf81j7kjtui
27 Oct 21
Prospectus supplement
8:51am
10-K
EX-10.51
olz7adqf vmttn3tjq
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
sc9vl ypf
12 Feb 18
Annual report
12:00am
10-K
904grnqa
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
0ity 7kfn8
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
oxzc35
12 Feb 18
Annual report
12:00am